HER2 and breast cancer—a phenomenal success story
DF Hayes - New England Journal of Medicine, 2019 - Mass Medical Soc
New England Journal of Medicine, 2019•Mass Medical Soc
HER2 and Breast Cancer — A Phenomenal Success Story | NEJM Skip to main content NEJM
Group Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to become a
physician, build your knowledge, lead a health care organization, and advance your career with
NEJM Group information and services. NEJM Evidence NEW! A digital journal for innovative
original research and fresh, bold ideas in clinical trial design and clinical decision-making.
NEJM Catalyst NEW! Peer-reviewed journal featuring in-depth articles to accelerate the …
Group Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to become a
physician, build your knowledge, lead a health care organization, and advance your career with
NEJM Group information and services. NEJM Evidence NEW! A digital journal for innovative
original research and fresh, bold ideas in clinical trial design and clinical decision-making.
NEJM Catalyst NEW! Peer-reviewed journal featuring in-depth articles to accelerate the …
Lasker Award for HER2 Discoveries
The 2019 Lasker–DeBakey Clinical Medical Research Award goes to scientists whose work on the human epidermal growth factor receptor 2 in breast cancer launched a new era in clinical research and the practice of oncology.
The New England Journal Of Medicine